Dasatinib-induced Reversible Demyelinating Peripheral Neuropathy and Successful Conversion to Nilotinib in Chronic Myelogenous Leukemia

Dasatinib, a tyrosine kinase inhibitor, is commonly used in the treatment of chronic myelogenous leukemia. A rare side effect is peripheral neuropathy. A 54-year-old woman experienced gradually accelerated dysesthesia and hypoesthesia in her extremities, 2 months following treatment with dasatinib....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Intern Med
Main Authors: Inoue, Hiroyasu, Taji, Hirofumi, Yamada, Kentaro, Iriyama, Chisako, Saito, Touko, Kato, Harumi, Yanada, Masamitsu, Yamamoto, Kazuhito, Matsukawa, Noriyuki
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society of Internal Medicine 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7644482/
https://ncbi.nlm.nih.gov/pubmed/32611965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.4824-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados